English
简体中文
Total: £ 56.28
Published Date: 2024-04-07 | Pages: 122 | Tables: 238 | Medical Devices & Consumables
Autologous Transfusion Products are products that collect, process and preserve a patient's own blood for use in situations where a patient requires transfusion during surgery or other medical procedures. Compared with traditional donor blood, autologous blood transfusion products can avoid potential risks such as infection and immune reaction transmitted by donor blood, and can also reduce problems such as shortage of donor blood and cost of donor blood.
The global market for Autologous Transfusion Products was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Autologous Transfusion Products was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Autologous Transfusion Products was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Autologous Transfusion Products was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Autologous Transfusion Products include LivaNova, Haemonetics, Getinge AB, Medtronic, Terumo, Braile Biomedica, Fresenius Kabi, Appligent and Wandong Health Sources, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Autologous Transfusion Products, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Autologous Transfusion Products by region & country, by Type, and by Application.
The Autologous Transfusion Products market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autologous Transfusion Products.
Market Segmentation
By Company
LivaNova
Haemonetics
Getinge AB
Medtronic
Terumo
Braile Biomedica
Fresenius Kabi
Appligent
Wandong Health Sources
Advancis Surgical
Macopharma SA
Asahi Kasei Medical
Stryker Corporation
Zimmer Biomet Holdings
Segment by Type:
Intraoperative Autologous Transfusion Products
Postoperative Autologous Transfusion Products
Dual Mode Autologous Transfusion Products
Segment by Application
Organ Transplant Surgery
Orthopedic Surgery
Heart Surgery
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Autologous Transfusion Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Autologous Transfusion Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Autologous Transfusion Products in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Autologous Transfusion Products Product Introduction
1.2 Global Autologous Transfusion Products Market Size Forecast
1.2.1 Global Autologous Transfusion Products Sales Value (2019-2030)
1.2.2 Global Autologous Transfusion Products Sales Volume (2019-2030)
1.2.3 Global Autologous Transfusion Products Sales Price (2019-2030)
1.3 Autologous Transfusion Products Market Trends & Drivers
1.3.1 Autologous Transfusion Products Industry Trends
1.3.2 Autologous Transfusion Products Market Drivers & Opportunity
1.3.3 Autologous Transfusion Products Market Challenges
1.3.4 Autologous Transfusion Products Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Autologous Transfusion Products Players Revenue Ranking (2023)
2.2 Global Autologous Transfusion Products Revenue by Company (2019-2024)
2.3 Global Autologous Transfusion Products Players Sales Volume Ranking (2023)
2.4 Global Autologous Transfusion Products Sales Volume by Company Players (2019-2024)
2.5 Global Autologous Transfusion Products Average Price by Company (2019-2024)
2.6 Key Manufacturers Autologous Transfusion Products Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Autologous Transfusion Products Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Autologous Transfusion Products
2.9 Autologous Transfusion Products Market Competitive Analysis
2.9.1 Autologous Transfusion Products Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Autologous Transfusion Products Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Transfusion Products as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Intraoperative Autologous Transfusion Products
3.1.2 Postoperative Autologous Transfusion Products
3.1.3 Dual Mode Autologous Transfusion Products
3.2 Global Autologous Transfusion Products Sales Value by Type
3.2.1 Global Autologous Transfusion Products Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Autologous Transfusion Products Sales Value, by Type (2019-2030)
3.2.3 Global Autologous Transfusion Products Sales Value, by Type (%) (2019-2030)
3.3 Global Autologous Transfusion Products Sales Volume by Type
3.3.1 Global Autologous Transfusion Products Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Autologous Transfusion Products Sales Volume, by Type (2019-2030)
3.3.3 Global Autologous Transfusion Products Sales Volume, by Type (%) (2019-2030)
3.4 Global Autologous Transfusion Products Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Organ Transplant Surgery
4.1.2 Orthopedic Surgery
4.1.3 Heart Surgery
4.1.4 Others
4.2 Global Autologous Transfusion Products Sales Value by Application
4.2.1 Global Autologous Transfusion Products Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Autologous Transfusion Products Sales Value, by Application (2019-2030)
4.2.3 Global Autologous Transfusion Products Sales Value, by Application (%) (2019-2030)
4.3 Global Autologous Transfusion Products Sales Volume by Application
4.3.1 Global Autologous Transfusion Products Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Autologous Transfusion Products Sales Volume, by Application (2019-2030)
4.3.3 Global Autologous Transfusion Products Sales Volume, by Application (%) (2019-2030)
4.4 Global Autologous Transfusion Products Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Autologous Transfusion Products Sales Value by Region
5.1.1 Global Autologous Transfusion Products Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Autologous Transfusion Products Sales Value by Region (2019-2024)
5.1.3 Global Autologous Transfusion Products Sales Value by Region (2025-2030)
5.1.4 Global Autologous Transfusion Products Sales Value by Region (%), (2019-2030)
5.2 Global Autologous Transfusion Products Sales Volume by Region
5.2.1 Global Autologous Transfusion Products Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Autologous Transfusion Products Sales Volume by Region (2019-2024)
5.2.3 Global Autologous Transfusion Products Sales Volume by Region (2025-2030)
5.2.4 Global Autologous Transfusion Products Sales Volume by Region (%), (2019-2030)
5.3 Global Autologous Transfusion Products Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Autologous Transfusion Products Sales Value, 2019-2030
5.4.2 North America Autologous Transfusion Products Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Autologous Transfusion Products Sales Value, 2019-2030
5.5.2 Europe Autologous Transfusion Products Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Autologous Transfusion Products Sales Value, 2019-2030
5.6.2 Asia Pacific Autologous Transfusion Products Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Autologous Transfusion Products Sales Value, 2019-2030
5.7.2 South America Autologous Transfusion Products Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Autologous Transfusion Products Sales Value, 2019-2030
5.8.2 Middle East & Africa Autologous Transfusion Products Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Autologous Transfusion Products Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Autologous Transfusion Products Sales Value
6.2.1 Key Countries/Regions Autologous Transfusion Products Sales Value, 2019-2030
6.2.2 Key Countries/Regions Autologous Transfusion Products Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Autologous Transfusion Products Sales Value, 2019-2030
6.3.2 United States Autologous Transfusion Products Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Autologous Transfusion Products Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Autologous Transfusion Products Sales Value, 2019-2030
6.4.2 Europe Autologous Transfusion Products Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Autologous Transfusion Products Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Autologous Transfusion Products Sales Value, 2019-2030
6.5.2 China Autologous Transfusion Products Sales Value by Type (%), 2023 VS 2030
6.5.3 China Autologous Transfusion Products Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Autologous Transfusion Products Sales Value, 2019-2030
6.6.2 Japan Autologous Transfusion Products Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Autologous Transfusion Products Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Autologous Transfusion Products Sales Value, 2019-2030
6.7.2 South Korea Autologous Transfusion Products Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Autologous Transfusion Products Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Autologous Transfusion Products Sales Value, 2019-2030
6.8.2 Southeast Asia Autologous Transfusion Products Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Autologous Transfusion Products Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Autologous Transfusion Products Sales Value, 2019-2030
6.9.2 India Autologous Transfusion Products Sales Value by Type (%), 2023 VS 2030
6.9.3 India Autologous Transfusion Products Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 LivaNova
7.1.1 LivaNova Company Information
7.1.2 LivaNova Introduction and Business Overview
7.1.3 LivaNova Autologous Transfusion Products Sales, Revenue and Gross Margin (2019-2024)
7.1.4 LivaNova Autologous Transfusion Products Product Offerings
7.1.5 LivaNova Recent Development
7.2 Haemonetics
7.2.1 Haemonetics Company Information
7.2.2 Haemonetics Introduction and Business Overview
7.2.3 Haemonetics Autologous Transfusion Products Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Haemonetics Autologous Transfusion Products Product Offerings
7.2.5 Haemonetics Recent Development
7.3 Getinge AB
7.3.1 Getinge AB Company Information
7.3.2 Getinge AB Introduction and Business Overview
7.3.3 Getinge AB Autologous Transfusion Products Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Getinge AB Autologous Transfusion Products Product Offerings
7.3.5 Getinge AB Recent Development
7.4 Medtronic
7.4.1 Medtronic Company Information
7.4.2 Medtronic Introduction and Business Overview
7.4.3 Medtronic Autologous Transfusion Products Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Medtronic Autologous Transfusion Products Product Offerings
7.4.5 Medtronic Recent Development
7.5 Terumo
7.5.1 Terumo Company Information
7.5.2 Terumo Introduction and Business Overview
7.5.3 Terumo Autologous Transfusion Products Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Terumo Autologous Transfusion Products Product Offerings
7.5.5 Terumo Recent Development
7.6 Braile Biomedica
7.6.1 Braile Biomedica Company Information
7.6.2 Braile Biomedica Introduction and Business Overview
7.6.3 Braile Biomedica Autologous Transfusion Products Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Braile Biomedica Autologous Transfusion Products Product Offerings
7.6.5 Braile Biomedica Recent Development
7.7 Fresenius Kabi
7.7.1 Fresenius Kabi Company Information
7.7.2 Fresenius Kabi Introduction and Business Overview
7.7.3 Fresenius Kabi Autologous Transfusion Products Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Fresenius Kabi Autologous Transfusion Products Product Offerings
7.7.5 Fresenius Kabi Recent Development
7.8 Appligent
7.8.1 Appligent Company Information
7.8.2 Appligent Introduction and Business Overview
7.8.3 Appligent Autologous Transfusion Products Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Appligent Autologous Transfusion Products Product Offerings
7.8.5 Appligent Recent Development
7.9 Wandong Health Sources
7.9.1 Wandong Health Sources Company Information
7.9.2 Wandong Health Sources Introduction and Business Overview
7.9.3 Wandong Health Sources Autologous Transfusion Products Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Wandong Health Sources Autologous Transfusion Products Product Offerings
7.9.5 Wandong Health Sources Recent Development
7.10 Advancis Surgical
7.10.1 Advancis Surgical Company Information
7.10.2 Advancis Surgical Introduction and Business Overview
7.10.3 Advancis Surgical Autologous Transfusion Products Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Advancis Surgical Autologous Transfusion Products Product Offerings
7.10.5 Advancis Surgical Recent Development
7.11 Macopharma SA
7.11.1 Macopharma SA Company Information
7.11.2 Macopharma SA Introduction and Business Overview
7.11.3 Macopharma SA Autologous Transfusion Products Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Macopharma SA Autologous Transfusion Products Product Offerings
7.11.5 Macopharma SA Recent Development
7.12 Asahi Kasei Medical
7.12.1 Asahi Kasei Medical Company Information
7.12.2 Asahi Kasei Medical Introduction and Business Overview
7.12.3 Asahi Kasei Medical Autologous Transfusion Products Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Asahi Kasei Medical Autologous Transfusion Products Product Offerings
7.12.5 Asahi Kasei Medical Recent Development
7.13 Stryker Corporation
7.13.1 Stryker Corporation Company Information
7.13.2 Stryker Corporation Introduction and Business Overview
7.13.3 Stryker Corporation Autologous Transfusion Products Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Stryker Corporation Autologous Transfusion Products Product Offerings
7.13.5 Stryker Corporation Recent Development
7.14 Zimmer Biomet Holdings
7.14.1 Zimmer Biomet Holdings Company Information
7.14.2 Zimmer Biomet Holdings Introduction and Business Overview
7.14.3 Zimmer Biomet Holdings Autologous Transfusion Products Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Zimmer Biomet Holdings Autologous Transfusion Products Product Offerings
7.14.5 Zimmer Biomet Holdings Recent Development
8 Industry Chain Analysis
8.1 Autologous Transfusion Products Industrial Chain
8.2 Autologous Transfusion Products Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Autologous Transfusion Products Sales Model
8.5.2 Sales Channel
8.5.3 Autologous Transfusion Products Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Autologous Transfusion Products Market Trends
Table 2. Autologous Transfusion Products Market Drivers & Opportunity
Table 3. Autologous Transfusion Products Market Challenges
Table 4. Autologous Transfusion Products Market Restraints
Table 5. Global Autologous Transfusion Products Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Autologous Transfusion Products Revenue Market Share by Company (2019-2024)
Table 7. Global Autologous Transfusion Products Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Autologous Transfusion Products Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Autologous Transfusion Products Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Autologous Transfusion Products Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Autologous Transfusion Products Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Autologous Transfusion Products
Table 13. Global Autologous Transfusion Products Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Transfusion Products as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Autologous Transfusion Products Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Autologous Transfusion Products Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Autologous Transfusion Products Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Autologous Transfusion Products Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Autologous Transfusion Products Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Autologous Transfusion Products Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Autologous Transfusion Products Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Autologous Transfusion Products Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Autologous Transfusion Products Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Autologous Transfusion Products Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Autologous Transfusion Products Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Autologous Transfusion Products Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Autologous Transfusion Products Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Autologous Transfusion Products Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Autologous Transfusion Products Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Autologous Transfusion Products Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Autologous Transfusion Products Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Autologous Transfusion Products Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Autologous Transfusion Products Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Autologous Transfusion Products Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Autologous Transfusion Products Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Autologous Transfusion Products Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Autologous Transfusion Products Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Autologous Transfusion Products Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Autologous Transfusion Products Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Autologous Transfusion Products Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Autologous Transfusion Products Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Autologous Transfusion Products Sales Value by Region (2019-2024) & (%)
Table 44. Global Autologous Transfusion Products Sales Value by Region (2025-2030) & (%)
Table 45. Global Autologous Transfusion Products Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Autologous Transfusion Products Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Autologous Transfusion Products Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Autologous Transfusion Products Sales Volume by Region (2019-2024) & (%)
Table 49. Global Autologous Transfusion Products Sales Volume by Region (2025-2030) & (%)
Table 50. Global Autologous Transfusion Products Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Autologous Transfusion Products Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Autologous Transfusion Products Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Autologous Transfusion Products Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Autologous Transfusion Products Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Autologous Transfusion Products Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Autologous Transfusion Products Sales Volume, (2025-2030) & (K Units)
Table 57. LivaNova Company Information
Table 58. LivaNova Introduction and Business Overview
Table 59. LivaNova Autologous Transfusion Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. LivaNova Autologous Transfusion Products Product Offerings
Table 61. LivaNova Recent Development
Table 62. Haemonetics Company Information
Table 63. Haemonetics Introduction and Business Overview
Table 64. Haemonetics Autologous Transfusion Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Haemonetics Autologous Transfusion Products Product Offerings
Table 66. Haemonetics Recent Development
Table 67. Getinge AB Company Information
Table 68. Getinge AB Introduction and Business Overview
Table 69. Getinge AB Autologous Transfusion Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Getinge AB Autologous Transfusion Products Product Offerings
Table 71. Getinge AB Recent Development
Table 72. Medtronic Company Information
Table 73. Medtronic Introduction and Business Overview
Table 74. Medtronic Autologous Transfusion Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Medtronic Autologous Transfusion Products Product Offerings
Table 76. Medtronic Recent Development
Table 77. Terumo Company Information
Table 78. Terumo Introduction and Business Overview
Table 79. Terumo Autologous Transfusion Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Terumo Autologous Transfusion Products Product Offerings
Table 81. Terumo Recent Development
Table 82. Braile Biomedica Company Information
Table 83. Braile Biomedica Introduction and Business Overview
Table 84. Braile Biomedica Autologous Transfusion Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Braile Biomedica Autologous Transfusion Products Product Offerings
Table 86. Braile Biomedica Recent Development
Table 87. Fresenius Kabi Company Information
Table 88. Fresenius Kabi Introduction and Business Overview
Table 89. Fresenius Kabi Autologous Transfusion Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Fresenius Kabi Autologous Transfusion Products Product Offerings
Table 91. Fresenius Kabi Recent Development
Table 92. Appligent Company Information
Table 93. Appligent Introduction and Business Overview
Table 94. Appligent Autologous Transfusion Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Appligent Autologous Transfusion Products Product Offerings
Table 96. Appligent Recent Development
Table 97. Wandong Health Sources Company Information
Table 98. Wandong Health Sources Introduction and Business Overview
Table 99. Wandong Health Sources Autologous Transfusion Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Wandong Health Sources Autologous Transfusion Products Product Offerings
Table 101. Wandong Health Sources Recent Development
Table 102. Advancis Surgical Company Information
Table 103. Advancis Surgical Introduction and Business Overview
Table 104. Advancis Surgical Autologous Transfusion Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Advancis Surgical Autologous Transfusion Products Product Offerings
Table 106. Advancis Surgical Recent Development
Table 107. Macopharma SA Company Information
Table 108. Macopharma SA Introduction and Business Overview
Table 109. Macopharma SA Autologous Transfusion Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Macopharma SA Autologous Transfusion Products Product Offerings
Table 111. Macopharma SA Recent Development
Table 112. Asahi Kasei Medical Company Information
Table 113. Asahi Kasei Medical Introduction and Business Overview
Table 114. Asahi Kasei Medical Autologous Transfusion Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Asahi Kasei Medical Autologous Transfusion Products Product Offerings
Table 116. Asahi Kasei Medical Recent Development
Table 117. Stryker Corporation Company Information
Table 118. Stryker Corporation Introduction and Business Overview
Table 119. Stryker Corporation Autologous Transfusion Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Stryker Corporation Autologous Transfusion Products Product Offerings
Table 121. Stryker Corporation Recent Development
Table 122. Zimmer Biomet Holdings Company Information
Table 123. Zimmer Biomet Holdings Introduction and Business Overview
Table 124. Zimmer Biomet Holdings Autologous Transfusion Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Zimmer Biomet Holdings Autologous Transfusion Products Product Offerings
Table 126. Zimmer Biomet Holdings Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Autologous Transfusion Products Downstream Customers
Table 130. Autologous Transfusion Products Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Autologous Transfusion Products Product Picture
Figure 2. Global Autologous Transfusion Products Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Autologous Transfusion Products Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Autologous Transfusion Products Sales Volume (2019-2030) & (K Units)
Figure 5. Global Autologous Transfusion Products Sales Price (2019-2030) & (US$/Unit)
Figure 6. Autologous Transfusion Products Report Years Considered
Figure 7. Global Autologous Transfusion Products Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Autologous Transfusion Products Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Autologous Transfusion Products Revenue in 2023
Figure 10. Autologous Transfusion Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Intraoperative Autologous Transfusion Products Picture
Figure 12. Postoperative Autologous Transfusion Products Picture
Figure 13. Dual Mode Autologous Transfusion Products Picture
Figure 14. Global Autologous Transfusion Products Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Autologous Transfusion Products Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Autologous Transfusion Products Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Autologous Transfusion Products Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Autologous Transfusion Products Price by Type (2019-2030) & (US$/Unit)
Figure 19. Product Picture of Organ Transplant Surgery
Figure 20. Product Picture of Orthopedic Surgery
Figure 21. Product Picture of Heart Surgery
Figure 22. Product Picture of Others
Figure 23. Global Autologous Transfusion Products Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Autologous Transfusion Products Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global Autologous Transfusion Products Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 26. Global Autologous Transfusion Products Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global Autologous Transfusion Products Price by Application (2019-2030) & (US$/Unit)
Figure 28. North America Autologous Transfusion Products Sales Value (2019-2030) & (US$ Million)
Figure 29. North America Autologous Transfusion Products Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe Autologous Transfusion Products Sales Value (2019-2030) & (US$ Million)
Figure 31. Europe Autologous Transfusion Products Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific Autologous Transfusion Products Sales Value (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Autologous Transfusion Products Sales Value by Country (%), 2023 VS 2030
Figure 34. South America Autologous Transfusion Products Sales Value (2019-2030) & (US$ Million)
Figure 35. South America Autologous Transfusion Products Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa Autologous Transfusion Products Sales Value (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa Autologous Transfusion Products Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions Autologous Transfusion Products Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions Autologous Transfusion Products Sales Volume (%), (2019-2030)
Figure 40. United States Autologous Transfusion Products Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States Autologous Transfusion Products Sales Value by Type (%), 2023 VS 2030
Figure 42. United States Autologous Transfusion Products Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe Autologous Transfusion Products Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe Autologous Transfusion Products Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe Autologous Transfusion Products Sales Value by Application (%), 2023 VS 2030
Figure 46. China Autologous Transfusion Products Sales Value, (2019-2030) & (US$ Million)
Figure 47. China Autologous Transfusion Products Sales Value by Type (%), 2023 VS 2030
Figure 48. China Autologous Transfusion Products Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan Autologous Transfusion Products Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan Autologous Transfusion Products Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan Autologous Transfusion Products Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea Autologous Transfusion Products Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea Autologous Transfusion Products Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea Autologous Transfusion Products Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia Autologous Transfusion Products Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia Autologous Transfusion Products Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia Autologous Transfusion Products Sales Value by Application (%), 2023 VS 2030
Figure 58. India Autologous Transfusion Products Sales Value, (2019-2030) & (US$ Million)
Figure 59. India Autologous Transfusion Products Sales Value by Type (%), 2023 VS 2030
Figure 60. India Autologous Transfusion Products Sales Value by Application (%), 2023 VS 2030
Figure 61. Autologous Transfusion Products Industrial Chain
Figure 62. Autologous Transfusion Products Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
